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Chronic bacterial colonization of the airways with opportunistic pathogens is the
primary cause of morbidity and mortality in cystic fibrosis (CF) patients.
Burkholderia cepacia complex (Bcc) organisms pose a particular challenge in CF
lung disease, due in part to their ability to trigger a fulminant pneumonia. This
study compares the U937 macrophage response to two Bcc species, B. cenocepacia
and Burkholderia multivorans, against Pseudomonas aeruginosa and Staphylococcus
aureus. The two Bcc strains demonstrated higher levels of U937 macrophage
internalization compared with both P. aeruginosa and S. aureus. Both the Bcc
strains also stimulated significantly greater levels of tumor necrosis factor-a and
interleukin-1b from macrophages when compared with P. aeruginosa. Further
examination of the macrophage response to B. multivorans demonstrated that the
lipopolysaccharide component of these bacteria was a potent inducer of proin-
flammatory cytokines and was shown to signal predominantly through the c-Jun
N-terminal kinase mitogen-activated protein kinase pathway. These studies
further characterize the host response to Bcc and in particular B. multivorans,
now the predominant Bcc species in many CF populations.
Introduction
Cystic fibrosis (CF) is an autosomal recessive disorder
caused by mutations in the cystic fibrosis transmembrane
conductance regulator (CFTR) gene (Riordan et al., 1989).
The CFTR dysfunction results in impaired transepithelial
ion flow, increased viscosity of submucosal gland secretions
and reduced mucociliary clearance of inhaled pathogens
(Gibson et al., 2003). Bacterial infection commences soon
after birth, with evidence of inflammation in bronchoalveo-
lar fluid. Subsequent persistent or recurrent infections lead
to chronic inflammation and significant lung damage in
later life. Staphylococcus aureus is frequently the first organ-
ism isolated from CF infants (Armstrong et al., 1997).
However, the predominant CF pathogen is Pseudomonas
aeruginosa and is associated with CF lung infections in all
age groups. The group of pathogens known as Burkholderia
cepacia complex (Bcc), which comprises at least 17 species
(Vanlaere et al., 2008, 2009), is particularly significant as
they are highly antibiotic resistant and many strains are
transmissible (Mahenthiralingam et al., 2001). In addition,
these pathogens have been associated with a high fever and
bacteremia, which progresses to a severe necrotizing and
fatal pneumonia (Isles et al., 1984). Bacterial uptake and
killing by macrophages plays an important role in pathogen
clearance. Some members of the Bcc are capable of surviving
and persisting within macrophages (Chu et al., 2004) due to
a significant delay in the fusion of the bacteria-containing
vacuole with lysosomes (Lamothe et al., 2007) and their
resistance to oxidative damage (Saini et al., 1999). The
macrophage–bacterial interaction is characterized by the
secretion of proinflammatory cytokines including interleu-
kin-1b (IL-1b) and tumor necrosis factor-a (TNF-a), facil-
itating the further recruitment of phagocytic cells to the
airway epithelium (Bonfield et al., 1995). In CF where
chronic infection is a feature, this response is often pro-
longed and the persistent stimulation of host cells can result
in a state of chronic activation leading to progressive
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pulmonary disease and premature mortality (Ramis et al.,
2000).
The contribution of bacterial lipopolysaccharide to the
inflammatory response from host macrophages is well
described. In Bcc organisms, both the lipid A moiety, which
plays a key role in the proinflammatory response, and the
adjacent inner core oligosaccharide differ from that of other
Gram-negative bacteria (Silipo et al., 2007). The outer
O-antigens, which determine the chemotype of the lipo-
polysaccharide, rough or smooth, may be less significant as
they do not correlate with the severity of infection and are
not distributed according to species (Vinion-Dubiel &
Goldberg, 2003). The unusual structural features of Bcc
lipopolysaccharide particularly in the lipid A core oligosac-
charide region may impact on the activation of cell signaling
cascades and play a role in the potent cytokine response
triggered by Bcc organisms compared with that of
P. aeruginosa lipopolysaccharide.
The aims of this study were to establish whether the
macrophage interaction between members of the Bcc differs
from that of P. aeruginosa and S. aureus and to determine which
macrophage signaling pathway(s) is activated by the lipopoly-
saccharide component of Burkholderia multivorans, the most
prevalent member of the Bcc in many CF populations.
Materials and methods
Bacterial strains and growth
All the bacterial strains are presented in Table 1. Staphylo-
coccus aureus and P. aeruginosa isolates were purchased from
the American Type Culture Collection (ATCC). Burkholder-
ia multivorans and B. cenocepacia strains were obtained from
the BCCM/LMG, University of Ghent, Belgium. All strains
were routinely grown in Luria–Bertani (LB) broth (Sigma-
Aldrich, Ireland) at 37 1C. The growth curves of each strain
were determined by growing the bacteria at 37 1C in LB
broth (pH 7.0) with shaking (200 r.p.m.). Aliquots were
taken at particular time intervals, the OD600 nm was recorded
and CFU mL1 of cultures was determined by plating serial
dilutions onto LB agar.
Cell line
The U937 human monocytic myeloid-derived cell line was
purchased from the ATCC and maintained in RPMI-1640
media supplemented with 10% fetal bovine serum (Sigma-
Aldrich). U937 monocytes were differentiated into macro-
phage-like cells by treatment with phorbol 12-myristate 13-
acetate (PMA; Sigma-Aldrich).
Antibiotic susceptibility of bacterial isolates
The minimum bactericidal concentration (MBC) of each
strain was determined for amikacin and ceftazidime using a
modified version of the method described by Ge et al.
(1999). Briefly, each test bacterium was grown to a mid-
logarithmic phase of growth at 37 1C in LB broth (OD600 nm
of 0.6). 1 106 cells mL1 were added in duplicate to LB
broth containing serial dilutions of amikacin or ceftazidime
in a 96-well plate (Corning Life Sciences, VWR Interna-
tional Ltd, Ireland). The plates were incubated at 37 1C for
24 h, after which 50mL from each well was spread onto LB
agar plates. Plates were incubated for 48 h to determine the
MBC of each antibiotic. Each plate contained the relevant
positive and negative controls.
Internalization of pathogens by U937
macrophages
Internalization assays were carried out on PMA-stimulated
monocytes using an adaptation of the gentamicin protection
assay (Isberg & Falkow, 1985) carried out by Martin & Mohr
(2000). A combination of 1 mg mL1 amikacin and
1 mg mL1 ceftazidime (both from Sigma-Aldrich) was
shown to effectively kill all isolates examined (data not
shown). PMA-stimulated monocytes seeded (5 105 cells
per well) in 24-well plates (Corning Life Sciences, VWR
International Ltd) were infected with S. aureus, P. aerugino-
sa, B. multivorans and B. cenocepacia at various multiplicities
of infection (MOIs). The plates were centrifuged for 5 min at
700 g to facilitate bacterial entry and incubated for 2 h at
37 1C in the presence of 5% CO2. Monolayers were washed
three times with phosphate-buffered saline (PBS) (pH 7.0)
and treated with a combination of amikacin/ceftazidime
(1 mg mL1, each) for 2 h to kill the extracellular bacteria.
After antibiotic treatment, the cells were washed a further
three times with PBS and the absence of viable extracellular
bacteria was confirmed by plating these washes onto LB
agar. The intracellular bacteria were released using 10 mM
EDTA (Sigma-Aldrich) and lysed with 0.25% Triton X-100
(Sigma-Aldrich). Intracellular bacteria were quantified by
plating serial dilutions of the lysate onto LB agar. The
percentage of internalization was determined as follows:
CFU mL1 recovered from macrophages
CFU mL1 applied to macrophages
 
 100
Table 1. Bacterial strains used in this study
Species Strain Source
Staphylococcus aureus ATCC 25923 Clinical
Pseudomonas aeruginosa PAO1 Clinical
Burkholderia multivorans LMG 13010 CF, Belgium
Burkholderia cenocepacia J2315 CF, ET12, UK
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Cytokine induction from U937 macrophages
U937 macrophages were stimulated with S. aureus,
P. aeruginosa, B. multivorans and B. cenocepacia at an MOI
of 50 : 1 for 24 h. Cytokine responses were determined
at a range of MOIs, with no significant difference in
the levels of cytokine secreted up to an MOI of 1000 : 1
(data not shown). We therefore chose a mid-range MOI
of 50 : 1 for the cytokine induction studies. Culture
supernatants were analyzed for TNF-a and IL-1b produc-
tion by enzyme-linked immunosorbent assay (ELISA)
(eBioscience, UK).
Isolation of rough lipopolysaccharide from
B. multivorans
Burkholderia multivorans rough lipopolysaccharide extrac-
tion was carried out as described previously by Galanos et al.
(1969). All reagents were supplied from Sigma-Aldrich.
After harvesting, cell pellets were washed twice with distilled
water and treated with ethanol, acetone and ether. Fifty
grams of dried bacteria were homogenized with 200 mL of
extraction buffer (liquid phenol, chloroform and petroleum
ether at a ratio of 2 : 5 : 8), centrifuged (10 000 g for 15 min)
and filtered. This process was repeated two more times and
the filtrates were pooled. Petroleum ether and chloroform
were evaporated and the phenol/lipopolysaccharide solution
was transferred into a glass tube and water was added
dropwise until the lipopolysaccharide precipitated. Precipi-
tated lipopolysaccharide was centrifuged (4000 g for
10 min), and washed three times with 80% phenol and three
times with ether. The precipitate was dried in vacuo,
resuspended in distilled water and centrifuged (100 000 g
for 4 h). After centrifugation, the supernatant was decanted
and the lipopolysaccharide pellet was dissolved in Limulus
amebocyte lysate water, lyophilized and weighed. The qual-
ity of lipopolysaccharide was analyzed by SDS-PAGE and
silver stained (Fig. 1).
Mitogen-activated protein (MAP) kinase
inhibition studies
U937 macrophages preincubated with 10 mM of SP600125
[c-Jun N-terminal kinase (JNK) inhibitor], SB203580 (P38
inhibitor) or PD98059 (ERK P42/44 inhibitor), individually
or in combination, for 1 h at 37 1C were stimulated with
100mg mL1 of B. multivorans lipopolysaccharide. All MAP
kinase inhibitors were purchased from Sigma-Aldrich. For
gene expression studies, total RNA was extracted after 2 and
4 h and analyzed for TNF-a and IL-1b gene expression as
described below. Culture supernatants were collected after
24 h and TNF-a and IL-1b secretion was detected by ELISA
(eBioscience).
Analysis of TNF-a and IL-1b gene expression by
real-time reverse transcriptase (RT)-PCR
Total RNA was isolated from lipopolysaccharide-stimulated
macrophages using RNAqueouss (Ambion, Ireland) and
converted to cDNA using a high-capacity cDNA reverse
transcription kit (Applied Biosystems, UK). Cytokine gene
expression was carried out using TNF-a and IL-1b primer/
probe sets (Applied Biosystems) by real-time RT-PCR
(7500 Real-Time PCR system, Applied Biosystems). A
glyceraldehyde-3-phosphate dehydrogenase (Applied Bio-
systems) probe was used as an endogenous control. Each
RT-PCR was carried out in a 20 mL final volume containing
1 mL primers/probe set, 10 mL universal PCR master mix
(Applied Biosystems), 2 mL of cDNA sample and 7mL
RNAse-free water. Each cycle consisted of an initial holding
temperature of 50 1C for 2 min, a denaturation step of 95 1C
for 10 min and 40 cycles of 95 1C for 15 s and 60 1C
for 1 min.
Statistical analysis
Results are expressed as mean values SEM. Sta-
tistical analysis was performed using ANOVA at a 95%
confidence level, and a P value of  0.05 was considered
significant.
Fig. 1. Identification of Burkholderia multivorans LMG 13010 rough
lipopolysaccharide. Lane 1, Mark12TM unstained standard MW marker
(Invitrogen, Bio Sciences, Ireland); lane 3, B. multivorans LMG 13010
lipopolysaccharide sample (5 mg mL1).
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Results and discussion
Internalization of bacterial species within U937
macrophages
Bcc macrophage internalization was compared with that of
P. aeruginosa and S. aureus using a variation of the gentami-
cin protection assay (Martin & Mohr, 2000) at five different
MOIs ranging from 5 : 1 to 500 : 1. The highest level of
uptake occurred at an MOI of 5 : 1 for all strains examined
(Fig. 2), indicating that at least for these organisms, there is a
specific and potentially saturable bacterial–macrophage in-
teraction involved. The reduced internalization of Burkhol-
deria strains at higher MOIs was reported previously in
epithelial cells and macrophages (Burns et al., 1996; Martin
& Mohr, 2000). We compared the internalization of Bcc
organisms with that of P. aeruginosa and S. aureus. Burkhol-
deria cenocepacia demonstrated a significantly greater level
of internalization by U937 macrophages compared with the
two non-Bcc species at each MOI examined (P = 0.002).
Burkholderia multivorans was also internalized in higher
numbers compared with the non-Bcc species at three of the
MOIs analyzed in this study. Uptake by macrophages,
although ultimately detrimental to bacteria, may facilitate
the triggering of a more potent immune response while the
bacteria are protected from antimicrobial therapy. Reports
of delayed clearance by macrophages of Bcc organisms
(Saini et al., 1999; Chu et al., 2004; Lamothe et al., 2007)
indicate that internalization may be an important survival
strategy for at least some Bcc organisms in the lung.
Previous literature demonstrated that alveolar macrophages
were not competent to phagocytose unopsonized P. aerugi-
nosa in vitro (Cheung et al., 2000), which may explain the
low rate of internalization of P. aeruginosa by U937 cells in
vitro reported here. Whether the uptake in these experi-
ments was receptor mediated, as a result of phagocytosis or a
combination of both was not determined, but under the
same in vitro conditions, a significant difference in the
macrophage internalization of these Bcc vs. non-Bcc species
was observed. This enhanced uptake, combined with the
previously reported delayed clearance by the macrophage,
may be an important survival or virulence strategy with
the potential to contribute to the rapid decline in lung
function associated with some strains from the Bcc group of
pathogens.
Cytokine induction from U937 macrophages in
response to pathogens
The proinflammatory cytokine response of U937 macro-
phages to Bcc species and to P. aeruginosa and S. aureus was
compared. Burkholderia multivorans or B. cenocepacia in-
duced significantly higher levels of TNF-a than the non-Bcc
species examined, with B. cenocepacia inducing over 25
times more TNF-a than P. aeruginosa (Fig. 3b). Zughaier
et al. (1999) demonstrated that unspeciated Bcc strains were
more potent TNF-a stimulators than both P. aeruginosa and
Stenotrophomonas maltophilia in human MonoMac6
macrophages (Zughaier et al., 1999). Our findings, using
two clinically important Bcc species, establish that macro-
phage exposure to these species can contribute to the
pronounced inflammation with potential deterioration of
the airway epithelia associated with this group of organisms.
Furthermore, IL-1b induction from the macrophages was
most pronounced in response to B. cenocepacia exposure
when compared with the other pathogens (Fig. 3a). In
contrast to TNF-a secretion, significantly less IL-1b was
induced by B. multivorans compared with B. cenocepacia. Of
the four species examined, S. aureus induced the second
highest concentration of IL-1b, which suggests that the
initial influx of IL-1b triggered by S. aureus in the early
stages of CF may cause sufficient epithelial damage to the
local environment, facilitating further colonization by Bcc
or P. aeruginosa organisms. In a comparative study of the
potency within the Bcc, De Soyza et al. (2004), using whole-
cell lysates, demonstrated increased potency of B. cenocepa-
cia compared with other Bcc species in TNF-a, but not
IL-1b induction from U937 monocytic cells (De Soyza et al.,
2004). Of the two Bcc species examined in our studies,
B. cenocepacia induced higher levels of both of these proin-
flammatory cytokines compared with the B. multivorans
strain. IL-1b cytokine is a significant mediator of the acute-
phase response, involved in a variety of cellular activities
implicated in lung damage (Laskin & Pendino, 1995), and
may be significant in the poor clinical outcome associated
with the J2315 strain of B. cenocepacia.





















Fig. 2. Percentage uptake (%) of Staphylococcus aureus, Pseudomonas
aeruginosa, Burkholderia multivorans and Burkholderia cenocepacia
pathogens by U937 macrophages after 2 h at various MOIs. Values
represent % uptake SEM of three independent assays.
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MAP kinase pathways involved in
lipopolysaccharide-induced IL-1b and TNF-a
induction from macrophages
Currently, B. multivorans is the predominant Bcc pathogen
present in the lungs of CF patients (Baldwin et al., 2008;
Mahenthiralingam et al., 2008). For this reason, the me-
chanisms of B. multivorans induction of proinflammatory
cytokines were further investigated using purified lipopoly-
saccharide, an important mediator of this response (Shaw
et al., 1995). The macrophage response to lipopolysacchar-
ide, consistent with the response from whole bacterial cells,
demonstrated significant levels of both IL-1b and TNF-a,
with over three times the amount of TNF-a induced
compared with IL-1b (Fig. 4).
Although B. multivorans lipopolysaccharide interacts
with toll-like receptor 4 (TLR4), the best-characterized

























































































































Fig. 3. (a) IL-1b and (b) TNF-a production from U937 macrophages
stimulated with Staphylococcus aureus, Pseudomonas aeruginosa, Bur-
kholderia multivorans and Burkholderia cenocepacia (MOI 50 : 1) for 24 h
compared with unstimulated cells. Values represent cytokine levels























































































































































































































Fig. 4. (a) IL-1b and (b) TNF-a production from U937 macrophages
stimulated with 100 mg mL1 of Burkholderia multivorans LMG 13010
lipopolysaccharide for 24 h. Cells were preincubated (1 h) with individual
or combination MAP kinase inhibitors. Values represent cytokine levels
(pg mL1) SEM. Statistically different from the lipopolysaccharide-
stimulated control cells (Po 0.05).
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reported that Bcc lipopolysaccharide can signal through
various TLRs depending on the lipopolysaccharide prepara-
tion (Shimomura et al., 2001). Following TLR engagement,
we were interested in the potential role of the three MAP
kinase cellular pathways in cytokine induction by B. multi-
vorans lipopolysaccharide. Using a variety of MAP kinase
inhibitors, the greatest inhibition of both IL-1b and TNF-a
secretion in response to lipopolysaccharide occurred with
the JNK MAP kinase inhibitor (Fig. 4). Inhibition of the
ERK (P42/44) pathway partially inhibited both IL-1b and
TNF-a responses to B. multivorans lipopolysaccharide. The
P38 MAP kinase inhibitor, however, demonstrated contrast-
ing results. Although this inhibitor had no effect on lipopo-
lysaccharide-induced TNF-a, it had a significant impact on
the reduction of IL-1b from the U937 macrophages, indicat-
ing the potential for the differential activation of these two
cytokines. All inhibitor combinations significantly decreased
IL-1b and TNF-a production. Inhibition of the ERK and
P38 pathways was established as being the least effective
in reducing TNF-a production, providing further evidence
of a central role for JNK pathway activation in this response
(Fig. 4b).
To investigate whether the inhibition observed was occur-
ring at the transcriptional level, real-time PCR was used to
examine TNF-a and IL-1b gene expression in the presence
of the MAP kinase inhibitors. Lipopolysaccharide-induced
TNF-a gene expression was not altered by the P38 inhibitor
at either 2 or 4 h (Fig. 5b), consistent with the lack of
inhibition on TNF-a secretion at 24 h (Fig. 4b), confirming
that this pathway is not central to TNF-a induction by this
species. However, despite significantly reducing IL-1b pro-
tein secretion at 24 h (Fig. 4a), IL-1b gene expression by Bcc
lipopolysaccharide remained unaltered in the presence of
the P38 inhibitor (Fig. 5a), suggesting that this pathway may
be involved indirectly in regulating IL-1b induction or that
there is additional regulation at the translational level. The
ERK (P42/44) and JNK MAP kinase inhibitors significantly
decreased the TNF-a gene expression response (Fig. 5b),
correlating with the reduction seen at the protein level (Fig.
4b). It should be noted that although the ERK inhibitor had
a profound effect at the transcriptional level at 2 and 4 h,
there was only a partial reduction at the TNF-a protein level
at 24 h, suggesting a later reactivation of this pathway.
Similar to the protein experiments, IL-1b gene expression
induced by B. multivorans lipopolysaccharide in the pre-
sence of the ERK (P42/44) and JNK inhibitors demonstrated
significant abrogation of this response from the inhibited
cells, confirming a key role for both of these MAP kinase
pathways in B. multivorans IL-1b induction (Fig. 5a). A
study by Bamford et al. (2007), in which the TNF-a response
to clinical isolates of Bcc was examined, determined that the
ERK (P42/44) and JNK MAPK inhibitors were more im-
portant than the P38 pathway (Bamford et al., 2007).
Therefore, while a combination of pathways may potentially
be activated as a consequence of bacterial–macrophage
interaction, in terms of B. multivorans cytokine production,
the JNK pathway is the most significant, with the ERK and


























































































































































































































Fig. 5. Relative expression of (a) IL-1b and (b) TNF-a genes from U937
macrophages stimulated with 100 mg mL1 lipopolysaccharide from
Burkholderia multivorans LMG 13010 for 2 h or 4 h. Cells were preincu-
bated (1 h) with individual or a combination of MAP kinase inhibitors.
Values represent relative gene expression SEM. Statistically different
from the lipopolysaccharide-stimulated control cells (Po 0.05).
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To conclude, the interaction of U937 macrophages with
Bcc strains results in a higher level of internalization and a
more potent proinflammatory response compared with
other pathogens including P. aeruginosa. The MAP kinase
pathways and in particular the JNK pathway play an
important role in the induction of that proinflammatory
response. From a clinical perspective, there are significant
differences in the host reaction to Bcc infection compared
with that of P. aeruginosa. Understanding the pathophysio-
logical basis for those differences will bring us closer toward
a more effective management of these infections in CF.
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